Business Description
Applied Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US03828A1016
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 568.36 | |||||
Equity-to-Asset | 0.57 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -3.72 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 43.8 | |||||
3-Year EPS without NRI Growth Rate | 44.1 | |||||
3-Year FCF Growth Rate | 43.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 206.15 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 11.61 | |||||
9-Day RSI | 24.3 | |||||
14-Day RSI | 33.08 | |||||
6-1 Month Momentum % | -3.1 | |||||
12-1 Month Momentum % | 193.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.3 | |||||
Quick Ratio | 2.3 | |||||
Cash Ratio | 2.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -55.7 | |||||
Shareholder Yield % | -26.25 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 23434.23 | |||||
Net Margin % | 48375.08 | |||||
FCF Margin % | 22369.97 | |||||
ROE % | -751.61 | |||||
ROA % | -190.55 | |||||
ROIC % | -161.56 | |||||
3-Year ROIIC % | 57.59 | |||||
ROC (Joel Greenblatt) % | -15526.46 | |||||
ROCE % | -356.16 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 7.38 | |||||
Price-to-Tangible-Book | 7.36 | |||||
EV-to-EBIT | -10 | |||||
EV-to-Forward-EBIT | -6.6 | |||||
EV-to-EBITDA | -10.05 | |||||
EV-to-Forward-EBITDA | -6.6 | |||||
EV-to-Revenue | -2342.44 | |||||
EV-to-Forward-Revenue | 12.33 | |||||
EV-to-FCF | -5.63 | |||||
Price-to-Net-Current-Asset-Value | 7.36 | |||||
Price-to-Net-Cash | 7.93 | |||||
Earnings Yield (Greenblatt) % | -10.01 | |||||
FCF Yield % | -8.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Applied Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | -0.303 | ||
EPS (TTM) (€) | -1.48 | ||
Beta | 2.33 | ||
Volatility % | 181.28 | ||
14-Day RSI | 33.08 | ||
14-Day ATR (€) | 0.227308 | ||
20-Day SMA (€) | 4.9755 | ||
12-1 Month Momentum % | 193.6 | ||
52-Week Range (€) | 1.64 - 6.85 | ||
Shares Outstanding (Mil) | 114.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Applied Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Applied Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Applied Therapeutics Inc Frequently Asked Questions
What is Applied Therapeutics Inc(STU:2UV)'s stock price today?
When is next earnings date of Applied Therapeutics Inc(STU:2UV)?
Does Applied Therapeutics Inc(STU:2UV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |